Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier

Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier

The Russian Federation and the member states of the Eurasian Economic Union (EAEU) are working on the creation of a common pharmaceutical market. EAEU marketing authorisation may be granted to those pharmaceutical companies whose activities comply with the Good Pharmacovigilance Practice (GVP). The...

Full description

Bibliographic Details
Main Authors:	I. I. Snegireva, E. O. Zhuravleva, N. Yu. Velts
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2020-12-01
Series:	Безопасность и риск фармакотерапии
Subjects:	drug authorisation eaeu good pharmacovigilance practice drug evaluation pharmacovigilance pharmacovigilance system master file
Online Access:	https://www.risksafety.ru/jour/article/view/195

Similar Items

Analysis of Noncompliances with Legislative Requirements in Pharmacovigilance Materials of Registration Dossiers
by: E. O. Zhuravleva, et al.
Published: (2021-12-01)

Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice
by: N. Yu. Velts, et al.
Published: (2023-03-01)

Risk Management Plan: An Expert Analysis of Changes to the EAEU Good Pharmacovigilance Practice Requirements for the Content and Submission of the Document
by: T. M. Bukatina, et al.
Published: (2023-03-01)

Analysis of Errors Identified during Regulatory Review of Risk Management Plans Submitted as Part of Registration Dossiers
by: A. O. Lovkova, et al.
Published: (2023-12-01)

Preparation for the Inspection of the Pharmacovigilance System
by: B. K. Romanov
Published: (2021-10-01)

Critical Overview of the Contents of Risk Management Plans for Medicines
by: T. M. Bukatina, et al.
Published: (2022-04-01)

Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
by: M. Abdrakhmanov, et al.
Published: (2022-04-01)

Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice
by: A. V. Matveev, et al.
Published: (2023-03-01)

New Edition of the EAEU Good Pharmacovigilance Practice: What Has Changed?
by: D. A. Rozhdestvensky
Published: (2023-03-01)

Typical pharmacovigilance system master file (PSMF)
by: B. K. Romanov, et al.
Published: (2018-02-01)

Changes to the EAEU Guideline on Good Pharmacovigilance Practices
by: B. K. Romanov
Published: (2023-03-01)

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01)

Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers
by: A. E. Krasheninnikov, et al.
Published: (2021-10-01)

Recommendations on Informational Monitoring of the Safety and Efficacy of Medicinal Products in the Russian Federation as Part of Pharmacovigilance
by: K. S. Milchakov
Published: (2022-10-01)

Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
by: Pramod Kumar Sharma, et al.
Published: (2016-01-01)

Training in post-authorization pharmacovigilance
by: Vivek Ahuja, et al.
Published: (2010-01-01)

Results of a Sociological Survey on the Needs of Drug Safety Monitoring Specialists for Information on the Creation of the Pharmacovigilance System Master File
by: N. G. Goloenko, et al.
Published: (2020-06-01)

Pharmacovigilance: Scope for a dermatologist
by: Bhanu Prakash, et al.
Published: (2011-01-01)

Pharmacovigilance: Empowering healthcare professionals
by: Mugoša Snežana S., et al.
Published: (2015-01-01)

Prospects of consumer-initiated adverse drug reaction reporting in cardiovascular pharmacovigilance
by: Vinu Wilson, et al.
Published: (2015-01-01)

Differences between the European and Eurasian Good Pharmacovigilance Practices
by: A. V. Matveev, et al.
Published: (2021-07-01)

Gender Differences in Adverse Drug Reactions Among Adult Patients Reported to the Iraqi Pharmacovigilance Center
by: Areej Atheer Alsaedi, et al.
Published: (2021-12-01)

Analysis of Docetaxel Adverse Drug Reactions: A Retrospective Study Based on Iraqi Pharmacovigilance Center Database
by: Ahmed M. Hameed, et al.
Published: (2020-12-01)

Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia
by: E. N. Tkhoseva, et al.
Published: (2022-06-01)

National strategy for the integration of pharmacovigilance in the Moroccan TB Control Program
by: Driss Soussi Tanani, et al.
Published: (2017-01-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
by: Prasad Thota, et al.
Published: (2018-01-01)

Evaluation of Pharmacovigilance System in Iran
by: Malahat Khalili, et al.
Published: (2022-07-01)

Research Progress of Antitumor Pharmacovigilance
by: Wenjuan SUN, et al.
Published: (2022-07-01)

PARTICULARITIES OF PHARMACOVIGILENCE ACTIVITY IN DENTISTRY
by: Ioana Maria Hunea, et al.
Published: (2019-04-01)

A Retrospective Analysis of Reporting of Adverse Drug Reactions in a Tertiary Care Teaching Hospital: One Year Survey
by: Anuj Kumar Pathak, et al.
Published: (2016-08-01)

Monitoring of adverse drug reactions is an important task of pharmacovigilance. Analysis of the regional department of State Expert Center of the Ministry of Health of Ukraine in Zaporizhzhia region
by: O. V. Kraydashenko, et al.
Published: (2017-04-01)

A pharmacovigilance Study on Critically Ill Patients Admitted In Beni-Suef University Teaching Hospital.
by: Alshimaa Mohamed Abdelmohymen, et al.
Published: (2021-06-01)

Current status and future prospects of pharmacovigilance in Pakistan
by: Rabia Hussain, et al.
Published: (2019-12-01)

Assessment of community pharmacists concerning pharmacovigilance in Iraq
by: Muhannad R. M. Salih, et al.
Published: (2016-01-01)

Periodic Benefit–Risk Evaluation Report: A Review of Changes
by: A. R. Titova, et al.
Published: (2023-03-01)

Challenges and experiences in establishing a zonal pharmacovigilance centre at Bangabandhu Sheikh Mujib Medical University: A 10-month journey
by: Elora Sharmin, et al.
Published: (2024-03-01)

A Survey on the Knowledge, Attitude and the Practice of Pharmacovigilance Among the Health Care Professionals in a Teaching Hospital in Northern India
by: Hardeep, et al.
Published: (2013-01-01)

Pharmacovigilance in India
by: Sarita Mulkalwar, et al.
Published: (2013-01-01)

AN INVESTIGATION INTO THE VALUE OF A STANDARDISED GLOBAL PHARMACOVIGILANCE REPORTING SYSTEM
by: Schurer, Maximillian Juan, et al.
Published: (2017-11-01)